STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serve… Read more
Market Cap & Net Worth: STAAR Surgical Company (STAA)
STAAR Surgical Company (NASDAQ:STAA) has a market capitalization of $881.18 Million ($881.18 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9798 globally and #4654 in its home market, demonstrating a -2.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying STAAR Surgical Company's stock price $17.85 by its total outstanding shares 49365953 (49.37 Million).
STAAR Surgical Company Market Cap History: 2015 to 2026
STAAR Surgical Company's market capitalization history from 2015 to 2026. Data shows growth from $352.47 Million to $881.18 Million (7.30% CAGR).
Index Memberships
STAAR Surgical Company is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.02% | #271 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1028 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.36 Trillion | 0.07% | #508 of 602 |
Weight: STAAR Surgical Company's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
STAAR Surgical Company Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how STAAR Surgical Company's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.82x
STAAR Surgical Company's market cap is 3.82 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $352.47 Million | $77.12 Million | -$6.53 Million | 4.57x | N/A |
| 2016 | $535.62 Million | $82.43 Million | -$12.13 Million | 6.50x | N/A |
| 2017 | $765.17 Million | $90.61 Million | -$2.14 Million | 8.44x | N/A |
| 2018 | $1.58 Billion | $123.95 Million | $4.97 Million | 12.71x | 317.08x |
| 2019 | $1.74 Billion | $150.19 Million | $14.05 Million | 11.56x | 123.59x |
| 2020 | $3.91 Billion | $163.46 Million | $5.91 Million | 23.92x | 661.39x |
| 2021 | $4.51 Billion | $230.47 Million | $27.51 Million | 19.56x | 163.83x |
| 2022 | $2.40 Billion | $284.39 Million | $39.66 Million | 8.43x | 60.41x |
| 2023 | $1.54 Billion | $322.42 Million | $21.35 Million | 4.78x | 72.17x |
| 2024 | $1.20 Billion | $313.90 Million | -$20.21 Million | 3.82x | N/A |
Competitor Companies of STAA by Market Capitalization
Companies near STAAR Surgical Company in the global market cap rankings as of March 18, 2026.
Key companies related to STAAR Surgical Company by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
STAAR Surgical Company Historical Marketcap From 2015 to 2026
Between 2015 and today, STAAR Surgical Company's market cap moved from $352.47 Million to $ 881.18 Million, with a yearly change of 7.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $881.18 Million | -22.69% |
| 2025 | $1.14 Billion | -4.94% |
| 2024 | $1.20 Billion | -22.17% |
| 2023 | $1.54 Billion | -35.70% |
| 2022 | $2.40 Billion | -46.83% |
| 2021 | $4.51 Billion | +15.25% |
| 2020 | $3.91 Billion | +125.25% |
| 2019 | $1.74 Billion | +10.22% |
| 2018 | $1.58 Billion | +105.87% |
| 2017 | $765.17 Million | +42.86% |
| 2016 | $535.62 Million | +51.96% |
| 2015 | $352.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of STAAR Surgical Company was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $881.18 Million USD |
| MoneyControl | $881.18 Million USD |
| MarketWatch | $881.18 Million USD |
| marketcap.company | $881.18 Million USD |
| Reuters | $881.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.